mk 0663 has been researched along with mefenamic acid in 3 studies
| Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (mefenamic acid) | Trials (mefenamic acid) | Recent Studies (post-2010) (mefenamic acid) |
|---|---|---|---|---|---|
| 549 | 173 | 265 | 1,180 | 158 | 267 |
| Protein | Taxonomy | mk 0663 (IC50) | mefenamic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 1.6 | |
| Myeloperoxidase | Homo sapiens (human) | 1.595 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.116 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.751 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.56 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 6.97 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 3.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ranong, CN; Sukcharoen, N | 1 |
| Jamil, MA; Mahdy, ZA; Maryasalwati, I; Nor Azlin, MI; Norzilawati, MN; Zainul Rashid, MR | 1 |
2 trial(s) available for mk 0663 and mefenamic acid
| Article | Year |
|---|---|
Analgesic effect of etoricoxib in secondary dysmenorrhea: a randomized, double-blind, crossover, controlled trial.
Topics: Adult; Analgesia; Analgesics; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Dysmenorrhea; Etoricoxib; Female; Humans; Mefenamic Acid; Placebos; Pyridines; Sulfones; Treatment Outcome | 2007 |
The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Dysmenorrhea; Etoricoxib; Female; Humans; Mefenamic Acid; Pyridines; Sulfones | 2008 |
1 other study(ies) available for mk 0663 and mefenamic acid
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |